IMAX公司
IMAX
50.82
-0.73
-1.42%
IMAX公司
US · IMAX
#2528 按市值排名
上市于 2011
50.82
-0.73
-1.42%
实时 - 追踪5344个代码 - 心跳于567秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 机构持股总比例下降了0.6个百分点。
机构持股
- 机构持股比例
- 100.10% -0.57pp
- 机构数量
- 310
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund82.40%
Individual/Insider18.34%
Hedge Fund6.78%
Sovereign Wealth Fund5.24%
Public Company3.79%
Government Pension Fund1.01%
Private Company0.52%
Insurance Company0.27%
Family Office/Trust0.10%
主要股东 截至 2026-06-11
Kevin Douglas
13.72% · 7.52M 股
Orbis Investment Management Limited
9.39% · 5.15M 股
Macquarie Investment Management Business Trust
5.35% · 2.94M 股
BlackRock
5.30% · 2.91M 股
GIC Private Limited
5.23% · 2.87M 股
Westfield Capital Management Company, L.P.
4.84% · 2.65M 股
Congress Asset Management Company, LLP
4.63% · 2.54M 股
Driehaus Capital Management LLC
4.27% · 2.34M 股
FMR
4.23% · 2.32M 股
Columbia Management Investment Advisers, LLC
3.23% · 1.77M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 20次买入 · 30次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Kevin Douglas | Independent Director | 13.72% |
| Richard Gelfond | Chief Executive Officer | 1.21% |
| Robert Lister | Chief Legal Officer & Senior EVP | 0.33% |
| Mark Welton | President of Imax Theatres | 0.26% |
| David Leebron | Lead Independent Director | 0.24% |
| Dana Settle | Independent Director | 0.13% |
| Pablo Calamera | Executive Vice President | 0.08% |
| Giovanni Dolci | Chief Sales Officer | 0.07% |
| Michael I. MacMillan | Independent Director | 0.07% |
| Eric Demirian | Independent Director | 0.07% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-14 | Giovanni Dolci | Chief Sales Officer | Other Derivative Acquisition | +2,578 | -- |
| 2026-09-09 | Robert Lister | Chief Legal Officer & Senior EVP | Open Market Disposition | -22,500 | $51.58 |
| 2026-08-24 | Mark Welton | President of Imax Theatres | Open Market Disposition | -30,000 | $54.47 |
| 2026-08-24 | Kenneth Weissman | Deputy General Counsel & Corporate Secretary | Open Market Disposition | -8,000 | $54.54 |
| 2026-08-23 | Natasha Fernandes | Chief Financial Officer | Open Market Disposition | -20,000 | $54.63 |
| 2026-08-19 | Richard Gelfond | Chief Executive Officer | Open Market Disposition | -100,000 | $53.23 |
| 2026-08-19 | Pablo Calamera | Executive Vice President | Open Market Disposition | -15,000 | $52.41 |
| 2026-08-18 | Richard Gelfond | Chief Executive Officer | Derivative Exercise and Sale | -356,757 | $31.90–53.27 |
| 2026-08-18 | Richard Gelfond | Chief Executive Officer | Intent to Sell (Form 144) | -205,504 | $53.71 |
| 2026-08-17 | Richard Gelfond | Chief Executive Officer | Intent to Sell (Form 144) | -151,253 | $50.55 |
| 2026-08-05 | Jose Zlatar | Senior VP of Finance & Principal Accounting Officer | Open Market Disposition | -500 | $49.90 |
| 2026-06-10 | Dana Settle | Independent Director | Other Derivative Acquisition | +3,390 | -- |
| 2026-06-10 | Dana Settle | Independent Director | Derivative Exercise and Retained | +3,390 | -- |
| 2026-06-10 | Michael I. MacMillan | Independent Director | Derivative Exercise and Sale | -1,849 | $42.12 |
| 2026-06-10 | Michael I. MacMillan | Independent Director | Other Derivative Acquisition | +3,390 | -- |
| 2026-06-10 | Michael I. MacMillan | Independent Director | Derivative Exercise and Retained | +1,541 | -- |
| 2026-06-10 | Eric Demirian | Independent Director | Derivative Exercise and Sale | -1,842 | $42.12 |
| 2026-06-10 | Eric Demirian | Independent Director | Other Derivative Acquisition | +3,390 | -- |
| 2026-06-10 | Eric Demirian | Independent Director | Derivative Exercise and Retained | +1,548 | -- |
| 2026-06-10 | Kevin Douglas | Independent Director | Other Acquisition | +3,390 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
IMAX公司 讨论区 0 条评论